Skip to main content
. 2019 Mar 28;13:1178221819835847. doi: 10.1177/1178221819835847

Figure 1.

Figure 1.

Proportion of lost to follow-up (LTFU) in non-OST and OST patient groups according to alcohol (A) and cannabis (B) consumption (ITT population). DU indicates former/current drug use and/or HCV transmission via drug abuse; non-OST, patients without OST; NDU, no former/current drug use/other mode of HCV transmission; OST, opioid substitution therapy.

*, P < .05 compared with OST.